Glanbia Sees Strong H1 2024 Growth, EPS Up 12.4%by Mark Eisenberg 15.08.2024Glanbia reports 12.4% EPS growth in H1 2024 amid strong demand and strategic acquisitions.
AI Helps ALS Patients Communicate Uniquelyby Lilu Anderson 15.08.2024Brain implants and AI voice technology enable ALS patients to communicate effectively.
Preparing for New U.S. Biotech Legislationby Lilu Anderson 15.08.2024Companies must adapt as U.S. advances biotech bill restricting Chinese suppliers.
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapyby Lilu Anderson 14.08.2024Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.
Meiji Yasuda Acquires Allstate’s Voluntary Benefitsby Mark Eisenberg 14.08.2024Japan's Meiji Yasuda buys Allstate's business for $2B to boost global profits by 2027.
BP Tech May Drill on Mars After NASA Dealby Lilu Anderson 14.08.2024BP's tech could explore Mars or Moon post NASA deal, sharing expertise from hostile environments.
Ogeechee Tech Launches Cybersecurity Clubby Lilu Anderson 14.08.2024Ogeechee Tech's new club boosts cybersecurity skills through training and competitions.
Amgen to Launch Tech and Innovation Hub in Indiaby Lilu Anderson 12.08.2024Amgen plans a new site in Hyderabad to boost digital capabilities and advance its medicine pipeline.
Hannover RE Outperforms with Strong P&C Growthby Mark Eisenberg 12.08.2024Hannover RE's net income soars to €603 million, driven by robust P&C reinsurance performance, exceeding expectations by 13%.
Amgen to Launch Innovation Hub in Hyderabadby Lilu Anderson 12.08.2024Amgen taps into India's talent with new Hyderabad innovation site for advancing biotechnology and AI.